Skip to main content

Consolidating food safety measures against COVID-19



The world is facing an extraordinarily unprecedented threat from the COVID-19 pandemic triggered by the SARS-CoV-2 virus. Global life has turned upside down, and that several countries closed their borders, simultaneously with the blockage of life cycle as a result of the shutdown of the majority of workplaces except the food stores and some few industries.

Main body

In this review, we are casting light on the nature of COVID-19 infection and spread, the persistence of SARS-CoV-2 virus in food products, and revealing the threats arising from the transmission of COVID-19 in food environment between stakeholders and even customers. Furthermore, we are exploring and identifying some practical aspects that must be followed to minimize infection and maintain a safe food environment. We also present and discuss some World Health Organization (WHO) guidelines-based regulations in food safety codes, destined to sustain the health safety of all professionals working in the food industry under this current pandemic.


The information compiled in this manuscript is supporting and consolidating the safety attributes in food environment, for a prospective positive impact on consumer confidence in food safety and the citizens’ public health in society. Some research is suggested on evaluating the use and potentiality of native and chemical modified basic proteins as possible practices aiming at protecting food from bacterial and viral contamination including COVID-19.


Coronaviruses are affiliated to the Coronaviridae family under the order Nidovirales. The word corona refers to crown-like spikes on the outer virus surface. Coronaviruses are a single-stranded RNA with tiny molecular size, 65–125 nm in diameter, and 26 to 32 kbs in length [1]. They are infectious to birds and several vertebrates, including humans, causing respiratory tract and gastrointestinal tract infections [2]. The severe acute respiratory syndrome coronavirus (SARS-CoV), H5N1 influenza A, H1N1 2009, and Middle East respiratory syndrome coronavirus (MERS-CoV) were globally reported to trigger acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), causing pulmonary failure which leads finally to death [3].

A severe acute respiratory syndrome (SARS) outbreak was recently reported by SARS-CoV, 2002, in Guangdong, China [1]. A decade after, another dangerous infectious coronavirus, i.e., Middle East respiratory syndrome coronavirus (MERS-CoV), erupted in the Middle Eastern countries leading to another endemic [4]. Most recently, COVID-19 has lately outbroken at the end of 2019, killing above eighteen hundred and infecting more than seventy thousand individuals during the first 50 days of its epidemic emergence in a business center of China, Wuhan [5, 6]. The outbreak of this obscure pneumonia in Wuhan city was associated with food, since most of the patients were reported to have visited the Huanan Seafood Wholesale Market [7]. The Chinese researchers called the novel virus Wuhan coronavirus or 2019 novel coronavirus (2019-nCov). Alternatively, the International Committee on Taxonomy of Viruses (ICTV) named the virus as SARS-CoV-2 and the disease as Covid-19. The COVID-19 is still a highly contagious disease, reporting over 23 million infection cases and harvesting over 800,000 death cases [5, 6].

Highly efficacious transmission of SARS-CoV-2 between human, globally experienced, is creating probably unprecedented pandemic at least for the last two centuries [7,8,9]. The widespread global travel activities and the ease of use could further boost this worldwide spread [10]. The interconnected international food trade and mutual dependence worldwide can create another threat if not well scrutinized and controlled.

Symptoms of COVID-19

It was reported that patients confirmed with COVID-19 mainly had respiratory signs and symptoms [11, 12]. In most cases, fever was reported, associated with a dry cough [13]. Vague gastrointestinal symptoms such as nausea, vomiting, and diarrhea were notably reported from a significant proportion of COVID-19 patients [11]. Myalgia or fatigue was also reported [13]. In contrast to human previously experienced coronavirus infections, upper respiratory symptoms are remarkably infrequent in COVID-19 patients [14]. A new onset of COVID-19 infection-associated psychosis potentially connected with immune-mediated neuropathogenesis was recently reported [15]. The viral load of SARS-CoV-2 reaches its peak within 5–6 days of symptom onset, i.e., significantly much quicker than SARS-CoV, which requires about 10 days. Severe COVID-19 cases can progress into acute respiratory distress syndrome (ARDS) [7].

Route of transmission, pathophysiology, and testing of SARS-CoV-2 infection

Coronaviruses are known viruses causing disease in humans and animals. Most strains uniquely infect the upper respiratory tract and cause mild common cold symptoms [16]. However, three coronaviruses, namely, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, can replicate in the lower respiratory tract, causing probably fatal pneumonia. SARS-CoV-2 belongs to the betacoronavirus genus. It is closely related to SARS-CoV, with 79% genetic similarity [17]. The species severe acute respiratory syndrome-related coronavirus is classifying 2019-nCoV and naming it SARS-CoV-2. Like other respiratory coronaviruses, SARS-CoV-2 is transmitted predominantly through droplets. Droplet transmission happens when a person comes into close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore exposed to potentially infective respiratory droplets on his or her mucosae (mouth and nose) or conjunctiva (eyes). Transmission can also happen through fomites in the sick person’s immediate environment [18]. After infection, the average incubation period is usually 4–5 days before symptoms appear; around 97% of symptomatic patients have manifestations in the first 10 days of exposure to the virus [19]. Based on the available information, there is no proof to propose the transmission of COVID-19 via fecal-oral route. However, it was reported that some stool samples of infected patients contained the RNA (ribonucleic acid) of COVID-19 might cause the infection [11, 20]. Clear evidence reported that the transmission of COVID-19 virus is due to droplets containing viable virus landed on any surface. It can be transmitted by self-inoculation via mucous membranes of the nose, eyes, and mouth [21,22,23]. Remarkably, about 108 viral copies were detected in only 1 ml of the infected person’s sputum [23, 24]. Consequently, the whole environment could be a source of infection via direct or indirect contact transmission [25,26,27]. Animals are suspected vectors of COVID-19 virus and are expected to be the cause of original infection and the current outbreak of epidemy, as confirmed by European Center for Disease Prevention and Control (ECDC).

SARS-CoV-2 infection’s pathophysiology is similar to SARS-CoV but with stronger inflammation reactions that can end by airways damage, depending on various host and virus factors that determine COVID-19 disease severity in patients. Old age and underlying chronic diseases are major host factors correlated to the disease severity [27]. Acute respiratory distress syndrome in severe COVID-19 can range from breathing difficulties, low blood oxygen level, and up to respiratory failure, which is the major death cause in 70% of COVID-19 deaths [28]. Also, cytokines storm in response to the viral infection together with associated secondary bacterial infections can lead to septic shock causing death in 28% of COVID-19 deaths. Most deadly cases manifested multiorgan failure due to uncontrolled inflammatory reactions particularly in cardiac, hepatic, and renal systems [29].

To confirm diagnosis of SARS-CoV-2 infection, direct virological tests mainly molecular diagnosis must be done to all suspected cases. Suspected cases are those with respiratory symptoms likely to be SARS-CoV-2 or healthcare workers with repeated risk of exposure to the virus. Reverse transcriptase-polymerase chain reaction tests are highly recommended [30]; however, other recent tests have emerged. Nasopharyngeal samples are best samples used to detect SARS-CoV-2 according to the CDC (Centers for Disease Control and Prevention) [31]. Nasal swabs or oropharyngeal swabs are also accepted. Lower respiratory tract samples have higher sensitivity than upper tract samples, but they are not used to avoid virus aerosols and spreading of the virus during sample collection [32].

Serological testing to detect viral antibodies indicates the patient was recently or previously infected with SARS-CoV-2. So, serological tests cannot be used alone to diagnose COVID-19 infection; moreover, it may take up to 21 days after symptom onset for seroconversion to detect immunoglobulin M and/or immunoglobulin G antibodies to SARS-CoV-2 [33]. Finally, the sensitivity and specificity of many commercially available serologic tests are not high. For example, false-positive test results can occur due to possible antibodies cross-reactivity with other coronaviruses strains. It is still unknown how long antibodies can persist after infection and whether the presence of antibody reflects protective immunity against future infections [34].

Hazards triggering COVID-19 virus transmission in food environments

Three main hazards can cause the spread of the COVID-19 virus in food environments, including contaminated food, infected food handlers, and contaminated food contact materials [35], as shown in Fig. 1.

Fig. 1
figure 1

The potential transmission pathway of coronaviruses via food products and processes [35]

The European Food Safety Authority (EFSA) declared that no confirmation is indicating food as a possible source of transmission of the virus (COVID-19) [36]. This conclusion is based on previous knowledge regarding the nature of other similar viruses such as SARS-CoV and MERS-CoV, assuming their similar route of transmission. This may explain the absence of the European Food Safety Authority (EFSA) participation in response to COVID-19.

It was reported that the threat of coronavirus infection depends on some factors, including the type of contaminated surfaces, the amount of virus, and the time of getting contact with the virus [37]. In order to stop the spread of COVID-19 infection, good hygiene practices should be extremely applied [26, 38].

Object exposure is a possible route for COVID-19 transmission [32]; it includes an inanimate object carrying a pathogen from one susceptible person to another, through touching the surface and then the eyes, nose, or mouth. The virus can remain viable and infectious for hours in air and for days on surfaces [39]. Viral stability of human coronaviruses, SARS-CoV-1 and SARS-CoV-2, was examined in aerosols and on various surfaces, i.e., plastic, stainless steel, copper, and cardboard [39, 40]. The coronavirus’s viability in the materials above was 3, 72, 72, 4, and 24 h, respectively [39]. Some information refers that food handlers in meat and poultry factories may be the primary source of indoor bioaerosols in the food industry via spreading microorganisms through contact, coughing, or sneezing and by their clothes [41].

Currently, there is no evidence suggesting that food or food packaging could be a possible route for COVID-19 transference to humans, or that humans can contaminate animal food. Product packaging should be taken out and left for air-drying as an additional precaution [42].

Persistence of coronavirus on food products

Human coronaviruses can persist on solid surfaces at room temperature for up to 9 days. However, at a temperature equal to or above 30 °C, they persist for a shorter duration. On the other hand, veterinary coronaviruses were shown to remain infectious on surfaces up to 28 days [23]. A recent review of human coronaviruses’ persistence on surfaces reported large variability, ranging from 2 h to 9 days [23]. The duration that the virus during which COVID-19 can persist on surfaces is not yet fully confirmed. However, it seems mostly to act like other coronaviruses.

Some viruses like avian influenza viruses and coronaviruses have the potential for foodborne transmissions. Foodborne viruses can survive for extended periods at low pH values from 3 to 4 and at high pH from 9 to 10 [43]. Until now, there are no reports on the transmission of SARS-CoV-2 by food. Studies to estimate the mode and time of virus survival in food matrices are in progress. For example, MERS-CoV has been demonstrated to survive up to 72 h in food at 4 °C [44].

Since COVID-19 virus possesses a fragile outer membrane, it is considered one of the enveloped viruses that are less stable in the environment and are more sensitive to oxidants, like chlorine. There is no confirmation about the survival of the COVID-19 virus in water or sewage. Enveloped viruses are expected to become highly inactivated and faster than the non-enveloped human enteric viruses which are known to be transmitted by water (such as adenoviruses, norovirus, rotavirus, and hepatitis A). As an example, a study found that an alternate human coronavirus survived just 2 days in dechlorinated tap water and in hospital wastewater at 20 °C [45]. Human coronaviruses, transmissible gastroenteritis coronavirus, and mouse hepatitis virus showed a 99.9% die-off from 2 days at 23 °C [46] and 2 weeks at 25 °C [47]. Heat, high or low pH, sunlight, and common disinfectants (such as chlorine) all speed up the virus die-off.

“Recent research has assessed the COVID-19 pathogen's ability to survive on various surfaces.” They have demonstrated that the virus can survive on plastic and stainless steel for up to 72 h, on copper for up to 4 h, and on cardboard for up to 24 h. The relative humidity and temperature were controlled in a laboratory setting for this investigation; thus, results should be taken with care in relation to actual settings [18].

Potential inactivation of coronaviruses on food contact surfaces

It is recommended by the World Health Organization (WHO) to safeguard all environmental surfaces by routine cleaning and disinfection procedures. Standard sanitization using water and detergents must be used to disinfect the viral loads from any surface throughout food manufacturing, packaging, and supply processes [38, 48]. Transmission of coronaviruses from contaminated surfaces to hands is not still wholly assured [23], while a transmission rate of 31.6% was confirmed for the influenza A virus, enabling the virus to be transmitted to hands within 5 s from contacting contaminated surfaces [49]. Human coronavirus (HCoV) strain 229E remains infectious for a period ranging from 2 h to 9 days on diverse kinds of materials. In case of (MERS) coronavirus, shorter persistence was recorded at elevated temperatures (30 °C or 40 °C) than lower ones. In terms of viral concentration, higher viral loads of SARS-CoV recorded longer persistence than lower ones. Higher relative humidity boosted the persistence of HCoV-229E than lower ones [23, 50]. In this review, we will focus on different probable ways to disinfect the viral loads on food products and related environments. We also shed light on control measures that affect similar viruses and therefore open the door for future research on COVID-19, as shown in Table 1 [23, 51].

Table 1 Potential measures to disinfect the viral loads on food products and related environment

Recommended hygiene practices for preventing the transmission of coronaviruses

The World Health Organization (WHO) advised the nations for physical separation and close working places. However, some industries and individuals are mandatorily still working in their normal workplaces. It has also issued some safety measures throughout the process of food handling and preparation. All food workers should safeguard the obligatory personal and environmental controls and Hazard Analysis Critical Control Point (HACCP) regulations to prevent the transmission of COVID-19 [44]. Implementation of food safety codes and good hygiene practices during food manufacturing, packaging, and supply processes decrease enormously the risk of contamination from food contact materials [44, 52].

In order to eliminate or reduce the risk of viral contamination on the surface of food products and packaging materials. When used appropriately, personal protective equipment (PPE) like masks and gloves can effectively stop the spread of viruses and diseases in the food sector. Additionally, the food industry is urged to keep a safe physical distance, implement stringent hygiene and sanitation procedures, and support frequent and efficient handwashing and sanitation at every stage of food processing, production, and marketing. These precautions will safeguard workers from the COVID-19 virus, keep the workforce healthy, and allow for the detection and ejection of infected employees and others in close contact with them [53].

Food workers include food manufacturers and catering workers who directly relate to unpacked food products due to their work. This category also includes personnel who may touch surfaces in contact with food or other surfaces in rooms where unpackaged food is produced. Thus, this term can be applied to managers, cleaners, maintenance contractors, suppliers, and food inspectors [54]. Food industry personnel should be aware of the symptoms of COVID-19. Food industry operators should prepare written recommendations for employees on reporting the symptoms of the disease and the suspension policy. The most important problem is employees’ ability to recognize symptoms at an early stage of the disease so that they can seek appropriate medical care, testing, and minimize the risk of spreading the virus [54].

The proper handwashing with soap and hot water for at least 20 s is considered acceptable hygiene practices by staff (as recommended by World Health Organization) [44]. It is also a good idea to frequently use alcohol-based hand sanitizers and to breathe properly (cover your mouth and nose when you cough or sneeze). Wipe disposal, routine cleaning, and disinfection of work areas and potential contact points, such as door handles, are also advised. Avoiding close contact with people who are coughing or sneezing is also a good idea [55]. Food workers can use gloves, but they must be often changed, and hands should be washed whenever gloves are removed or change gloves to avoid subsequent food contamination [44]. Gloves must be changed after nonfood-related activities, such as manually opening/closing doors and emptying trash cans. When wearing gloves, food workers should not touch their mouth and eyes, since the COVID-19 virus can contaminate disposable gloves. Wearing disposable gloves can create a false sense of security, leading personnel to wash their hands less often than necessary. Then, handwashing is a more serious protective barrier to infection than wearing disposable gloves. It is crucial to remind that gloves do not provide complete protection against contamination with patients’ flora; thus, hands must still be decontaminated after wearing them [56]. And if not used properly, gloves might contribute to the spread of infections [57]. Food industry enterprises must ensure proper sanitation and instruct staff to wash their hands thoroughly and often. Hand sanitizers can be used as an additional measure, but should not replace handwashing [58].

Keeping a physical distance to minimize the contact between potentially infected and healthy people is an important measure to slow down the quick spread of COVID-19. All food processing companies should follow physical distance guidelines as far as possible. The World Health Organization recommendations necessitate maintaining at least 1-m distance between employees [44]. In cases where the food production environment or process makes it difficult to comply with this recommendation, employers should consider possible measures to protect workers such as staggering jobs on both sides of production lines so that employees are not facing each other. The use of personal protective equipment (PPE) should become standard practice in high-risk areas in the premises of enterprises where ready-to-eat foods are produced.

Transportation and delivery of food raw materials and food products

The main attention to meet the food industry’s sanitary and hygienic requirements is paid to prevent the entrance and spread of the COVID-19 virus into the food enterprises. A virus can only enter office premises if an infected person enters the premises or brings in infected products or objects. Drivers and other food delivery personnel must not leave vehicles at the time of delivery. Drivers should be provided with alcohol-based hand antiseptics, disinfectants, and paper towels. Disposable containers and packaging should be used to avoid the need for disinfection of any returns. If reusable containers are used, appropriate hygiene protocols must be followed [38]. Drivers delivering food to premises should be aware of the potential risks associated with COVID-19 contact transmission. The virus can be transmitted by contact with an infected surface or shaking hands with an infected person. Surfaces that are more likely to be affected by the virus include surfaces that are most often touched, such as the steering wheel of a vehicle, door handles, and mobile devices. Therefore, hand hygiene combined with physical distance is of paramount importance along with disinfection contact surfaces to prevent cross-contamination [38].

The risk of transmitting COVID-19 should be reduced by identifying surfaces and objects most often touched in retail spaces and ensuring regular cleaning and disinfection. Examples of such surfaces and objects are shopping trolleys and baskets, door handles, and scales for customers [38]. Providing napkins (or other disinfectants) for cleaning the handles of carts and baskets; or the appointment of staff to disinfect the handles of carts and baskets after each use, cleaning and frequent disinfection of accessories used in the store (scoops, tongs, left-luggage offices), open doors if possible, to reduce contact open counters and shelves in retail stores [55].

Although some consumers believe that there is a risk of getting COVID-19 through open food stalls and shelves, there is currently no scientific evidence that food can be a virus transmission source. However, it is essential to maintain acceptable hygiene standards near open counters and shelves, such as salad bars, shelves with fresh produce, and bakery products [38]. Consumers are always advised to wash their fruits and vegetables before eating. Customers and store staff must strictly observe personal hygiene at any time near open counters and shelves. Self-service in stores should be laid out in plastic/cellophane or paper packaging. For displaying bakery products in retail stores, plexiglass display cases should be used, and each product should be placed in a separate package using forceps when serving customers.

Food irradiation as a possible solution to fight COVID-19

Irradiation effect on viruses is inversely proportional to its structural complexity. Large-sized viruses are more sensitive to ionized radiation than the smaller ones. Viruses require higher doses of irradiation than bacteria and fungi because of their minute sizes. However, viruses with double-stranded nucleic acid (dsRNA and dsDNA) are more resistant to UV irradiation than single-stranded nucleic acid (ssRNA and ssDNA). The lethal effect of ionizing radiation on viruses increases in the presence of oxygen. Viruses irradiated in a liquid medium are more sensitive than in dried or frozen samples [59].

The mechanism of radiation for viral inactivation occurs by the destruction of replicating nucleic acid by two ways, either directly through radiolytic cleavage and cross-linking the genetic material or indirectly via free radicals on nucleic acids and proteins [60]. Using cobalt-60 as a source of gamma irradiation is in general an efficacious and safe laboratory way for the inactivation of the infection specimen. The Centers for Disease Control and Prevention (CDC) have used a high dose (2 × 106 rad) to inactivate SARS-CoV-infected serum specimens [61]. A research group also deduced that the same range of dose 3–4.5 × 106 rad is needed to inactivate viruses in monoclonal antibody preparations [62]. The D10 range for viruses in the Coronaviridae family is estimated to be up to 3.6 kGy [63].

Another study revealed that the viruses were completely inactivated by a 1 M rad irradiation dose on SARS-COV [64]. The absorbed dose of gamma irradiation depends on many factors such as sample volume, sample origin, sample composition, irradiation temperature, distance to irradiation source, and others [60]. Two Kev (kilo-electronvolts) irradiation electron energy from electron beam irradiation was required to interact with Covid-19 virus for the highest energy loss and complete activity destruction based on the gene sequence collected from Wuhan patients [65].

UV radiation was categorized into three levels (AVA, UVB, and UVC) based on their influence on SAR-CoV toxicity: 320-400, 280-320, and 200-280 nm, respectively. UVA is weakly absorbed by DNA and RNA and is less effective than UVC and UVB in inducing pyrimidine dimers. However, additional genetic damage may occur through the production or reactive oxygen species, which cause oxidization of bases and strand breaks [66]. UVB may induce pyrimidine dimers but less efficiently than UVC by 20- to 100-fold [67]. RNA and DNA bases can absorb UVC, causing the photochemical fusion of two adjacent pyrimidines into covalently linked dimers and rendering them non-pairing bases [67]. Illumination with different wavelengths also influenced activities of SARS and MERS virus in blood: UVA [68] and UV-B light [69]. These commercial systems could reduce SARS and MERS virus activities in plasma or platelet concentrates to different degrees. Methylene blue plus visible light was also found able of inactivating coronaviruses in plasma [70].

UV-C lamps could be utilized to supplement existing hospital cleaning and disinfection of SARS-CoV-2-infected surfaces as reported by Lualdi et al. (2021). When it comes to choosing, setting, and confirming UV-C lights, there are a few simple guidelines to follow. Photochromic UV-C dosimeters may be a valuable tool for readily checking that an appropriate UV-C dose has been supplied in the absence of devices specialized to direct irradiance verification [71].

Basic proteins as a possible surface treatment against foodborne COVID-19 virus

Basic proteins, either native or chemically modified, were reported as both wide-spectral antibacterial [72,73,74,75] and nonspecific antiviral active substances [76,77,78,79,80,81,82]. This dual activity can be largely invested in food protection and preservation based on previous results [74, 83,84,85,86,87] as food may be contaminated by both bacteria and virus. Chemically modified proteins can have their carboxyl groups (on their aspartyl/glutamyl residues) neutralized by grafting the alcohol groups during esterification on protein molecules, transforming the protein net charge into positive, and becoming cationic proteins with also enhanced hydrophobicity coming from the grafted alkyl groups as shown in Fig. 2 and Fig. 3 [88, 90]. These positive charges enable them to chemically complex and hence inactivate naked DNA or RNA [89, 91, 92].

Fig. 2
figure 2

Esterification reaction [88]

Fig. 3
figure 3

Potential electrostatic interactions between basic proteins and nucleic acids (DNA and RNA) [89]

The main mechanism of the cationic of action against bacteria is through disturbing the cell membrane and cell wall structures, mainly through targeting the negatively charged components in the cell membrane, i.e., phospholipids by the positively charged proteins [93,94,95,96,97]. Alternatively, the mechanism of the antiviral action is envisaged to occur during viral replication where the virus is released from its coat, and thus, the negative charge on the phosphate backbone of viral DNA or RNA is disclosed and becoming subjected and liable to the electrophilic attack of the positively charged basic proteins [98, 99]. So, these basic proteins can attack any virus if it could exist in site during the phase of replication. Since virus is multiplying rapidly and thus disclosing negatively charged fragments, it will be an easy target for the basic protein action. The ability of these proteins to complex DNA may disturb its functional pathways particularly during replication. A thick coat of proteins usually protects viral DNA or RNA, but it is totally bare at the moment of replication. Therefore, the success of this strategy depends on the availability of viral DNA or RNA in the naked status during the replication process.

Lactoferrin is a native cationic protein with nonspecific antiviral activity [100]. Native basic protein, lactoferrin, was found effective against plant viruses [100]. Moreover, lactoferrin was even reported active against COVID-19 in human being, and that it is commercially available for different medical application mainly as antibacterial or antiviral under commercial formulas. More recently, this was reported as a direct remedy for COVID-19 based in a medical case study on 75 COVID-19 patients [101] when administered as liposomal bovine lactoferrin (LLF) nutritional syrup food supplement (32 mg of LF/10 ml plus 12 mg of vitamin C). As the same treatment at lower dose prevented the disease in healthy persons, it may prospectively be used in food protection against contamination with that virus. This may also refer to the potentiality of other cationic proteins either native or chemically modified to act the same function.

Globally, these results suggest a wide-spectrum specificity of these chemically modified proteins against different viruses and pathogenic bacteria nominating them as potential effective candidate in treating food products as a precautionary measure against contamination with COVID-19.


This review highlights the food security guidelines aiding at overcoming the current pandemic peacefully. Generally, the most important precaution is to keep the COVID-19 virus or other viruses out of the food environment which is in continuous contact with every human being. Future preventive intervention may invest some bioactive natural products, lactoferrin, and chemically modified proteins in cleaning and keeping fresh food products out of the reach of viral contamination. Key measures are required by upgrading the cleaning and sanitation measures, disinfecting surfaces, and educating staff on the virus and how to protect themselves and others. Combined protocols such as handwashing, physical distancing, sanitizing hands, and other material should be added and improved. Generally, new ways and means should be investigated to counteract potential food contamination. Specifically, it is urgently needed to evaluate the use and potentiality of native and chemical modified basic proteins as possible practices for protecting food from bacterial and viral contamination including COVID-19.

Availability of data and materials

Not applicable



Acute lung injury


Acute respiratory distress syndrome


Centers for Disease Control and Prevention

dsRNA and dsDNA:

Double-stranded nucleic acid


European Center for Disease Prevention and Control


The European Food Safety Authority


Food and Drug Administration


Hazard Analysis Critical Control Point


Human coronavirus


International Committee on Taxonomy of Viruses




Liposomal bovine lactoferrin


Middle East respiratory syndrome coronavirus


Personal protective equipment


Ribonucleic acid


Severe acute respiratory syndrome coronavirus


Severe acute respiratory syndrome

ssRNA and ssDNA):

Single-stranded nucleic acid


World Health Organization


2019 novel coronavirus


  1. Zhong N, Zheng B, Li Y, Poon L, Xie Z, Chan K, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s republic of China, in February, 2003. Lancet. 2003;362(9393):1353–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lombardi AF, Afsahi AM, Gupta A, Gholamrezanezhad A. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article. Radiol Med. 2021;126(4):561–9.

    Article  PubMed  Google Scholar 

  4. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013;23(8):986.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92.

    Article  CAS  PubMed  Google Scholar 

  6. Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;105924.

  7. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus inWuhan, China. Lancet. 2020;395:497–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019- nCoV) coronavirus. Am J Respir Crit Care Med. 2020;201:7–8.

    Article  CAS  Google Scholar 

  9. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382(8):692–4.

    Article  CAS  PubMed  Google Scholar 

  10. Biscayart C, Angeleri P, Loveras S, Chaves T, Schlagenhauf P, Rodriguez- Morales AJ. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): what advice can we give to travellers? — interim recommen- dations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis. 2020:101567.

  11. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83(3):217–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J. 2020;133(9):1015–24.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, et al. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551–5.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods MolBiol. 2015;1282:1–23.

    Article  CAS  Google Scholar 

  17. Gorbalenya A, Baker S, Baric R, De Groot R, Drosten C, Gulyaeva A, et al. Coronaviridae study group of the international committee on taxonomy of viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–44.

    Article  CAS  Google Scholar 

  18. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wong MC, Huang J, Lai C, Ng R, Chan FK, Chan PK. Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis. J Inf Secur. 2020;81(2):e31–8.

    Article  CAS  Google Scholar 

  21. Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92(3):235–50.

    Article  CAS  PubMed  Google Scholar 

  22. Dowell SF, Simmerman JM, Erdman DD, Wu JS, Chaovavanich A, Javadi M, et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis. 2004;39(5):652–7.

    Article  PubMed  Google Scholar 

  23. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–1.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected: interim guidance, 19 march 2020: World Health Organization; 2020. Available at:

    Google Scholar 

  27. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):e0235458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. Trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Coffey K, Diekema DJ, Morgan DJ. Interpreting SARS-CoV-2 test results. JAMA. 2021;326(15):1528–9.

    Article  CAS  PubMed  Google Scholar 

  31. Centers for Disease Control and Prevention (CDC), 2020 C. Food safety and coronavirus disease 2019 (COVID-19). Centers for Disease Control and Prevention last reviewed: January 20, 2022 (archived document). Available at :

  32. Centers for Disease Control and Prevention (CDC). Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). 2020. Updated 25 October, 2021 Available at:

  33. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778–85.

    Article  CAS  PubMed  Google Scholar 

  34. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–34.

    Article  CAS  PubMed  Google Scholar 

  35. Yekta R, Vahid-Dastjerdi L, Norouzbeigi S, Mortazavian AM. Food products as potential carriers of SARS-CoV-2. Food Control. 2021;123:107754.

    Article  CAS  PubMed  Google Scholar 

  36. European Food Safety Authority (EFSA), (2020) Coronavirus: no evidence that food is a source or transmission route 09 Mar, 2020 Availabel at :

  37. Lau AC, Yam LY, So LK. Management of critically ill patients with severe acute respiratory syndrome (SARS). Int J Med Sci. 2004;1(1):1–10.

    Article  PubMed  PubMed Central  Google Scholar 

  38. World Health Organization & Food and Agriculture Organization of the United Nations. (2020). COVID-19 and food safety: guidance for food businesses: interim guidance, 07 April 2020. World Health Organization. Available at :

  39. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. N Engl J Med. 2020;382:1564-7.

  40. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Michaels B. Handling money and serving ready-to-eat food. Food Serv Technol. 2002;2(1):1–3.

    Google Scholar 

  42. World Health Organization (WHO). Coronavirus disease (COVID-19): food safety for consumers, guidance for food businesses: interim guidance, 06 April 2020: World Health Organization; 2020b. Available at :

    Google Scholar 

  43. Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis. 2006;12(12):1888–94.

    Article  PubMed  PubMed Central  Google Scholar 

  44. World Health Organization (WHO). 2020. Coronavirus disease 2019 (COVID-19) situation report Available at:–32. Access at :04/05/2020

  45. Wang XW, Li JS, Zhen B, Kong QX, Song N, Xiao WJ, et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005;126:171–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Gundy P, Gerba CP, Pepper IL. Survival of coronaviruses in water and wastewater. Food Environ Virol. 2009;1:10–4.

    Article  Google Scholar 

  47. Casanova L, Rutalal WA, Weber DJ, Sobsey MD. Survival of surrogate coronaviruses in water. Water Res. 2009;43(7):1893–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. World Health Organization (WHO). Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts: interim guidance, 17 march 2020: World Health Organization; 2020b. Available at :

    Google Scholar 

  49. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis. 1982;146(1):47–51.

    Article  CAS  PubMed  Google Scholar 

  50. Ijaz MK, Brunner AH, Sattar SA, Nair Rama C, Johnson-Lussenburg CM. Survival characteristics of airborne human coronavirus 229E. J Gen Virol. 1985;66(12):2743–8.

    Article  PubMed  Google Scholar 

  51. Duan SM, Zhao XS, Wen RF, Huang JJ, Pi GH, Zhang SX. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–55.

    PubMed  Google Scholar 

  52. Food and Agriculture Organization of the United Nations (FAO). Codex alimentarius: food hygiene basic texts. 2nd ed. 2001. Available at:

  53. Joint, FAO.(2020). Codex alimentarius : ensuring food safety during the COVID-19 pandemic - a Codex observer view. Available at:

  54. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis. 2020;221(11):1757–61.

    Article  CAS  PubMed  Google Scholar 

  55. Prajapati P, Desai H, Chandarana C. Hand sanitizers as a preventive measure in COVID-19 pandemic, its characteristics, and harmful effects: a review. J Egypt Public Health Assoc. 2022;97:6.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Tenorio AR, Badri SM, Sahgal NB, Hota B, Matushek M, Hayden MK, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis. 2001;32(5):826–9.

    Article  CAS  PubMed  Google Scholar 

  57. Patterson JE, Vecchio J, Pantelick EL, Farrel P, Mazon D, Zervos MJ, et al. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med. 1991;91(5):479–83.

    Article  CAS  PubMed  Google Scholar 

  58. Kratzel A, Todt D, V'kovski P, Steiner S, Gultom M, Thao TTN, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols. Emerg Infect Dis. 2020;26(7):1592–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Farkas J. Physical methods of food preservation. In: Doyle MP, Beuchat LR, editors. Food microbiology: fundamentals and frontiers. 3rd ed. Washington: ASM Press; 2007. p. 685–712.

    Google Scholar 

  60. Hume AJ, Ames J, Rennick LJ, Duprex WP, Marzi A, Tonkiss J, et al. Inactivation of RNA viruses by gamma irradiation: a study on mitigating factors. Viruses. 2016;8(7):204.

    Article  CAS  PubMed Central  Google Scholar 

  61. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–66.

    Article  CAS  PubMed  Google Scholar 

  62. Grieb T, Forng RY, Brown R, Owolabi T, Maddox E, McBain A, et al. Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations. Biologicals. 2002 Sep;30(3):207–16.

    Article  CAS  PubMed  Google Scholar 

  63. Hewitt P, Leelawardana S. In: Agriculture D, editor. Gamma irradiation as a treatment to address pathogens of animal biosecurity concern CC by 3.0. Canberra: Commonwealth of Australia; 2014.

    Google Scholar 

  64. Feldmann F, Shupert W, Haddock E, Twardoski B, Feldmann H. Gamma irradiation as an effective method for inactivation of emerging viral pathogens. Am J Trop Med Hyg. 2019;100(5):1275–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Feng G, Liu L, Cui W, Wang F. Electron beam irradiation on novel coronavirus. Chinese Phys B. 2020;29:4.

    Article  CAS  Google Scholar 

  66. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B. 2001;63:88–102.

    Article  CAS  PubMed  Google Scholar 

  67. Perdiz D, Grof P, Mezzina M, Nikaido O, Moustacchi E, Sage E. Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells. J Biol Chem. 2000;275:26732–42.

    Article  CAS  PubMed  Google Scholar 

  68. Hashem AM, Hassan AM, Tolah AM, Alsaadi MA, Abunada Q, Damanhouri GA. Amotosalen and ultraviolet a light efficiently inactivate MERS-coronavirus in human platelet concentrates. Transfus Med. 2019;29:434–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Keil SD, Bowen R, Marschner S. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion. 2016;56:2948–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, Müller TH, et al. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. Vox Sang. 2020;115(3):146–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Lualdi M, Cavalleri A, Bianco A, Biasin M, Cavatorta C, Clerici M, et al. Ultraviolet C lamps for disinfection of surfaces potentially contaminated with SARS-CoV-2 in critical hospital settings: examples of their use and some practical advice. BMC Infect Dis. 2021;21:594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Sitohy M, Osman A. Antimicrobial activity of native and esterified legume proteins against gram-negative and gram-positive bacteria. Food Chem. 2010;120:66–73.

    Article  CAS  Google Scholar 

  73. Sitohy M, Mahgoub S, Osman A, El-Masry R, Al-Gaby A. Extent and mode of action of cationic legume proteins against listeria monocytogenes and salmonella Enteritidis. Probiotics Antimicrob Proteins. 2013;5:195–205.

    Article  CAS  PubMed  Google Scholar 

  74. Mahgoub S, Osman A, Sitohy M. Inhibition of growth of pathogenic bacteria in raw milk by legume protein esters. J Food Prot. 2011;74:1475–81.

    Article  CAS  PubMed  Google Scholar 

  75. Mahgoub SA, Osman AO, Sitohy MZ. Impeding bacillus spore germination in vitro and in milk by soy glycinin during long cold storage. J Gen Appl Microbiol. 2016;62:52–9.

    Article  CAS  PubMed  Google Scholar 

  76. Sitohy M, Billaudel S, Haertlé T, Chobert JM. Antiviral activity of esterified α-lactalbumin and β-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines. J Agric Food Chem. 2007;2007(55):10214–20.

    Article  CAS  Google Scholar 

  77. Sitohy M, Scanu M, Besse B, Mollat C, Billaudel S, Haertlé T, et al. Influenza virus a subtype H1N1 is inhibited by methylated [beta]-lactoglobulin. J Dairy Res. 2010;77:411.

    Article  CAS  PubMed  Google Scholar 

  78. Sitohy M, Besse B, Billaudel S, Haertlé T, Chobert J-M. Antiviral action of methylated β-lactoglobulin on the human influenza virus a subtype H3N2. Probiotics Antimicrob Proteins. 2010a;2:104–11.

    Article  CAS  PubMed  Google Scholar 

  79. Taha SH, Mehrez MA, Sitohy MZ, Abou Dawood AGI, Abd-El Hamid MM, Kilany WH. Effectiveness of esterified whey proteins fractions against Egyptian lethal avian influenza a (H5N1). Virol J. 2010;7:330.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Abdelbacki AM, Taha SH, Sitohy MZ, Abou Dawood AI, Abd-El Hamid MM, Rezk AA. Inhibition of tomato yellow leaf curl virus (TYLCV) using whey proteins. Virol J. 2010;7:1–6.

    Article  CAS  Google Scholar 

  81. Sitohy M, Dalgalarrondo M, Nowoczin M, Besse B, Billaudel S, Haertlé T, et al. The effect of bovine whey proteins on the ability of poliovirus and Coxsackie virus to infect Vero cell cultures. Int Dairy J. 2008;18:658–68.

    Article  CAS  Google Scholar 

  82. Chobert J-M, Sitohy M, Billaudel S, Dalgalarrondo M, Haertlé T. Anti cyto megalo viral activity of esterified milk proteins and L-polylysines. J Molecular Microbiol Biotech. 2007;13:255–8.

    Article  CAS  Google Scholar 

  83. Osman A, Goda HA, Sitohy M. Storage stability of minced beef supplemented with chickpea legumin at 4 C as a potential substitute for nisin. LWT. 2018;93:434–41.

    Article  CAS  Google Scholar 

  84. Osman A, Mahgoub S, Sitohy M. Hindering milk quality storage deterioration by mild thermization combined with methylated chickpea protein. Int Food Res J. 2014:21.

  85. Osman A, Mahgoub S, El-Masry R, Al-Gaby SM. Extending the technological validity of r aw buffalo m ilk at room temperature by esterified legume proteins. J Food Process Preserv. 2014;38:223–31.

    Article  CAS  Google Scholar 

  86. Osman AO, Mahgoub SA, Sitohy MZ. Preservative action of 11S (glycinin) and 7S (β-conglycinin) soy globulin on bovine raw milk stored either at 4 or 25 C. J dairy res. 2013;80:174–83.

    Article  CAS  PubMed  Google Scholar 

  87. Mahgoub SA, Sitohy MZ, Osman AO. Counteracting recontamination of pasteurized milk by methylated soybean protein. Food Bioprocess Technol. 2013;6:101–9.

    Article  CAS  Google Scholar 

  88. Sitohy M, Chobert JM, Haertlé T. Study of factors influencing protein esterification using β-lactoglobulin as a model. J Food Biochem. 2000;24:381–98.

    Article  CAS  Google Scholar 

  89. Sitohy M, Chobert JM, Gaudin JC, Renac T, Haertlé T. When positively charged milk proteins can bind to DNA. J Food Biochem. 2002;26:511–32.

    Article  Google Scholar 

  90. Sitohy M, Chobert J-M, Gaudin J-C, Haertlé T. Esterified milk proteins inhibit DNA replication in vitro. Int J Biol Macromol. 2001;29:259–66.

    Article  CAS  PubMed  Google Scholar 

  91. Sitohy M, Chobert J-M, Haertlé T. Study of the formation of complexes between DNA and esterified dairy proteins. Int Dairy J. 2001;11:873–83.

  92. Sitohy M, Chobert J-M, Schmidt M, Gozdzicka-Jozefiak A, Haertlé T. Interactions between esterified whey proteins (α-lactalbumin and β-lactoglobulin) and DNA studied by differential spectroscopy. J Protein Chem. 2001c;20:633–40.

    Article  CAS  PubMed  Google Scholar 

  93. Sitohy MZ, Mahgoub SA, Osman AO. In vitro and in situ antimicrobial action and mechanism of glycinin and its basic subunit. Int J Food Microbiol. 2012;154:19–29.

    Article  CAS  PubMed  Google Scholar 

  94. Osman A, Daidamony G, Sitohy M, Khalifa M, Enan G. Soybean glycinin basic subunit inhibits methicillin resistant-vancomycin intermediate Staphylococcus aureus (MRSA-VISA) in vitro. Int J Appl Res Nat Prod. 2016;9:17–26.

    CAS  Google Scholar 

  95. Sitohy MZ, Osman AO, Mahgoub SA. Bioactive proteins against pathogenic and spoilage bacteria. J Funct Food Health Dis. 2014;4:451–62.

    Article  Google Scholar 

  96. Abdel-Shafi S, Al-Mohammadi A-R, Osman A, Enan G, Abdel-Hameid S, Sitohy M. Characterization and antibacterial activity of 7s and 11s globulins isolated from cowpea seed protein. Molecules. 2019;24:1082.

    Article  CAS  PubMed Central  Google Scholar 

  97. Abdel-Shafi S, Osman A, Enan G, El-Nemer M, Sitohy M. Antibacterial activity of methylated egg white proteins against pathogenic G+ and G− bacteria matching antibiotics. SpringerPlus. 2016;5:983.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Sitohy M, Chobert J-M, Karwowska U, Gozdzicka-Jozefiak A, Haertlé T. Inhibition of bacteriophage M13 replication with esterified milk proteins. J Agric Food Chem. 2006;54:3800–6.

    Article  CAS  PubMed  Google Scholar 

  99. Sitohy M, Chobert J-M, Haertlé T. Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins and L-polylysines. J Agric Food Chem. 2005;53:3727–34.

    Article  CAS  PubMed  Google Scholar 

  100. Sitohy M, Taha S, Osman A, Abdel-Hamid M, Hamed A, Abdelbacki A. Antiviral action of native and methylated lactoferrin and β-lactoglobulin against potato virus Y (PVY) infected into potato plants grown in an open field. Antibiotics. 2020;9:430.

    Article  CAS  PubMed Central  Google Scholar 

  101. Serrano G, Kochergina I, Albors A, Diaz E, Oroval M, Hueso G, et al. Liposomal lactoferrin as potential preventative and cure for COVID-19. Int J Res Health Sci. 2020;8:8–15.

    Article  Google Scholar 

Download references


Not applicable.


Not applicable

Author information

Authors and Affiliations



AA: Conceptualization, wrote the original draft, preparation, review, editing and supervision. DHA wrote the original draft, preparation, review and editing. RA wrote the original draft, preparation, review and editing. AE wrote the original draft and preparation. BSMS wrote the original draft, preparation. ASE wrote the original draft and preparation. MS wrote the original draft, preparation, review, editing and supervision. All authors approved the final manuscript.

Corresponding authors

Correspondence to Dina H. Amin or Reham M. M. Abd El-kader.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abolmaaty, A., Amin, D.H., Abd El-kader, R.M.M. et al. Consolidating food safety measures against COVID-19. J. Egypt. Public. Health. Assoc. 97, 21 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • COVID-19
  • Food environment
  • Food safety
  • Good hygiene practice